The Animal Core for Addiction Related Behaviors of the NIDA P30 Center at Temple University will support collaborative NIH-funded research projects using in vivo rodent models in order to advance scientific knowledge on drugs of abuse, addiction, pain and the intersection of drugs of abuse with HIV/AIDS.
One aim of the Core is to provide the scientific expertise, personnel, equipment and other resources that are necessary to assess drug reinforcement, reward, reinstatement, and related endpoints of cognition and emotional function in rats and mice as needed to rigorously evaluate potential new therapeutic compounds and targets, as well as to elucidate neurobiological mechanisms underlying addiction. Another aim of the Core is to provide mutant rodent models to P30 collaborating investigators in order to enable study of specific molecules and pathways in vivo. Breeding animals in a central facility reduces the expense and promotes access of these valuable models to multiple researchers. Core personnel will work with investigators to design experiments including an emphasis on appropriate controls, data analysis, and result interpretation. If requested by collaborators, the Animal Core will provide training in behavioral methods, or Core staff will perform the tests independently. The Core offers the following approaches: intravenous and oral drug and ethanol self- administration, operant responding for food or sucrose, conditioned place preference and aversion, intracranial self-stimulation, learning and memory assessments, anxiety- and depression-like behavioral tests, use of stress models and other methods as needed. New innovative behavioral assessments and animal models are proposed in this renewal application in order to enhance the impact of the research supported by the Animal Core for Addiction Related Behaviors. These include the application of behavioral economic methods and intermittent access paradigms to drug self-administration studies, measurements of ultrasonic vocalization to assess positive and negative affect during behavioral testing, breeding of transgenic Cre rats, and support of humanized mouse models of HIV-1 infection. The Core serves as a national resource by providing the knowledge, skills and equipment necessary to enhance research programs and to promote extension of NIH-funded projects to include behavioral endpoints and animal models relevant to substance abuse research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
2P30DA013429-21
Application #
9845444
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
21
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Hicks, Callum; Huang, Peng; Ramos, Linnet et al. (2018) Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats. ACS Chem Neurosci 9:1327-1337
Dziedowiec, Emily; Nayak, Sunil U; Gruver, Keenan S et al. (2018) Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians. Neuroscience 386:214-222
Simmons, Steven J; Gregg, Ryan A; Tran, Fionya H et al. (2018) Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats. Addict Biol 23:102-110
Hill, Jeremy D; Zuluaga-Ramirez, Viviana; Gajghate, Sachin et al. (2018) Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. Br J Pharmacol :
Cotto, Bianca; Li, Hongbo; Tuma, Ronald F et al. (2018) Cocaine-mediated activation of microglia and microglial MeCP2 and BDNF production. Neurobiol Dis 117:28-41
Ward, Sara Jane; Castelli, Francesca; Reichenbach, Zachary W et al. (2018) Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sci 195:1-5
Liu, Jeffrey J; Sharma, Kirti; Zangrandi, Luca et al. (2018) In vivo brain GPCR signaling elucidated by phosphoproteomics. Science 360:
Oliver, Chicora F; Simmons, Steven J; Nayak, Sunil U et al. (2018) Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. Drug Alcohol Depend 186:75-79
Zewde, Ashenafi Mebratu; Yu, Frances; Nayak, Sunil et al. (2018) PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects. J Neurosci Methods 293:284-288
Rom, Slava; Zuluaga-Ramirez, Viviana; Reichenbach, Nancy L et al. (2018) Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation. J Neuroinflammation 15:25

Showing the most recent 10 out of 343 publications